Ivor Royston

Ivor Royston Email and Phone Number

Chairman of the Board @ San Diego, CA, US
San Diego, CA, US
Ivor Royston's Location
San Diego, California, United States, United States
Ivor Royston's Contact Details
About Ivor Royston

BiopharmaceuticalMedical Oncology

Ivor Royston's Current Company Details
Sanare Pharmaceuticals Corp

Sanare Pharmaceuticals Corp

Chairman of the Board
San Diego, CA, US
Ivor Royston Work Experience Details
  • Sanare Pharmaceuticals Corp
    Chairman Of The Board
    Sanare Pharmaceuticals Corp
    San Diego, Ca, Us
  • Geneditor Biologics Corp.
    Executive Chairman
    Geneditor Biologics Corp. Apr 2023 - Present
  • Viracta Therapeutics, Inc., A Nasdaq Listed Biotech Company [Virx]
    Non-Executive Member Board Of Directors
    Viracta Therapeutics, Inc., A Nasdaq Listed Biotech Company [Virx] Sep 2022 - Present
    Member of the Science & Technology Committee
  • Viracta Therapeutics, Inc., A Nasdaq Listed Biotech Company [Virx]
    President, Ceo, Founder, And Executive Board Member
    Viracta Therapeutics, Inc., A Nasdaq Listed Biotech Company [Virx] Dec 2014 - Sep 2022
    Viracta Therapeutics is a public clinical stage oncology company focused on novel therapies for virus-associated cancers. The lead program is based on a novel targeted therapy with an oral combination drug product, termed NanaVal for cancers containing the genome of the Epstein-Barr Virus (EBV). NanaVal is currently being studied in a late-stage pivotal clinical trial for advanced EBV-positive lymphomas and a Stage 1b/2 clinical trial for advanced EBV-positive nasopharyngeal carcinoma.
  • Biocept, Inc. - Personalized Medicine From A Liquid Biopsy, A Nasdaq Listed Company [Bioc]
    Member Board Of Directors
    Biocept, Inc. - Personalized Medicine From A Liquid Biopsy, A Nasdaq Listed Company [Bioc] Jul 2010 - Present
    Biocept is a liquid biopsy company that detects and analyzes both circulating tumor cells and cell free DNA in the blood and bodily fluids, such as cerebrospinal fluid to detect and analyze cancer cells
  • Syndax Pharmaceuticals - A Nasdaq Listed Biotech Company [Sndx]
    Member Board Of Directors
    Syndax Pharmaceuticals - A Nasdaq Listed Biotech Company [Sndx] Jul 2010 - Mar 2017
    Served on the Nomination & Governance Committee, and Science & Technology Committee
  • Forward Ventures , A Specialized Life Science Venture Capital Fund
    Founding Managing Partner
    Forward Ventures , A Specialized Life Science Venture Capital Fund Jul 1990 - Mar 2017
    Forward Ventures had 5 consecutive LP funds with over $400 million under management. The Fund specialized in early company formation and development in the life sciences.
  • Targegen, Inc.
    Chairman Of The Board Of Directors
    Targegen, Inc. Jul 2002 - Oct 2010
    Us
    Targegen was a targeted therapy company that developed the drug fedratinib for treating myelofibrosis. Aquired by Sanofi. Later restructured as Impact Bioscience and then aquired by Celgene/BMS
    View
  • Ligocyte Pharmaceuticals, Inc. (Aquired By Takeda)
    Chairman Of The Board Of Directors
    Ligocyte Pharmaceuticals, Inc. (Aquired By Takeda) Apr 2006 - Apr 2010
    Ligocyte completed development of a norovirus vaccine, and company acquired by Takeda.
  • Morphotek - Acquired By Eisai, Inc
    Chairman Of The Board Of Directors
    Morphotek - Acquired By Eisai, Inc Apr 2004 - Jun 2007
    Improved monoclonal antibody clinical development to novel cancer cell targets. Intimately involved in sale of company to Eisai.
  • Cancervax, Inc, Nasdaq Listed Biotech Company,
    Chairman Of The Board Of Directors
    Cancervax, Inc, Nasdaq Listed Biotech Company, 2001 - 2006
    Cancer vaccine company which merged with Micromet, Inc. and later aquired by Amgen
  • Sidney Kimmel Cancer Center
    President, Ceo, Founder,Board Member
    Sidney Kimmel Cancer Center Jul 1990 - Jun 2000
    Us
    Non-profit cancer research institute
    View
  • Idec, Inc - Nasdaq Listed Company [Idec]
    Founder, Consultant, Board Member
    Idec, Inc - Nasdaq Listed Company [Idec] Jul 1985 - Jun 1992
    IDEC developed the first monoclonal antibody, Rituxan, for lymphoma approved by FDA - now standard of care. IDEC later merged with Biogen in 2003/
  • Hybritech Incorporated A Nasdaq Listed Company [Hybr]
    Founder, Consultant, Board Member
    Hybritech Incorporated A Nasdaq Listed Company [Hybr] Apr 1978 - Jun 1986
    Hybritech was the first biotechnology company in the San Diego area. It pioneered the development of monoclonal antibodies for diagnostic use and developed the PSA test for prostate cancer, which became standard of care for the early diagnosis and monitoring of prostate cancer. Hybritech was acquired by Lilly in 1986.

Ivor Royston Skills

Venture Capital Lifesciences Biotechnology Start Ups Biopharmaceuticals Oncology Commercialization Pharmaceutical Industry Medical Devices Corporate Development Mergers And Acquisitions Technology Transfer Strategy Immunology Entrepreneurship Drug Development Venture Financing Drug Discovery Due Diligence Angel Investing Strategic Planning Private Equity Business Strategy Clinical Development Investments Business Development Cancer Research Licensing Clinical Trials Healthcare

Ivor Royston Education Details

  • The Johns Hopkins University School Of Medicine
    The Johns Hopkins University School Of Medicine
    Medicine
  • The Johns Hopkins University
    The Johns Hopkins University
    Human Biology
  • The George Washington University
    The George Washington University

Frequently Asked Questions about Ivor Royston

What company does Ivor Royston work for?

Ivor Royston works for Sanare Pharmaceuticals Corp

What is Ivor Royston's role at the current company?

Ivor Royston's current role is Chairman of the Board.

What is Ivor Royston's email address?

Ivor Royston's email address is ir****@****cta.com

What is Ivor Royston's direct phone number?

Ivor Royston's direct phone number is +185867*****

What schools did Ivor Royston attend?

Ivor Royston attended The Johns Hopkins University School Of Medicine, The Johns Hopkins University, The George Washington University.

What are some of Ivor Royston's interests?

Ivor Royston has interest in Arts And Culture, Science And Technology, Life Science Investing, Focus On Bio Pharmaceuticals And Devices.

What skills is Ivor Royston known for?

Ivor Royston has skills like Venture Capital, Lifesciences, Biotechnology, Start Ups, Biopharmaceuticals, Oncology, Commercialization, Pharmaceutical Industry, Medical Devices, Corporate Development, Mergers And Acquisitions, Technology Transfer.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.